However, the World Health Organization (WHO) estimates that in some developing lands, only 5 percent of those who need ARV therapy have access to the drugs.
Kuid Maailma Tervishoiuorganisatsiooni (WHO) arvestuste järgi saab arengumaades seda ravi endale lubada kõigest 5 protsenti abivajajatest.